S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Home
Investing
ETFs
USA
AMEX
SAP SE ADRhedged (SAPH)
SAP SE ADRhedged (SAPH) Options

SAP SE ADRhedged (SAPH)

31.101

0.0184

(0.06%)

Closed June 16 3:00PM

31.50

0.399

(1.28%)

After Hours: 6:59PM

SAP SE ADRhedged (SAPH) Options

SAPH Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
21.00	8.20	11.90	0.00	10.05	0.00	0.00 %	0	0	-
22.00	7.20	10.90	0.00	9.05	0.00	0.00 %	0	0	-
23.00	6.20	9.90	0.00	8.05	0.00	0.00 %	0	0	-
24.00	5.20	8.90	0.00	7.05	0.00	0.00 %	0	0	-
25.00	4.20	7.90	0.00	6.05	0.00	0.00 %	0	0	-
26.00	3.20	6.90	0.00	5.05	0.00	0.00 %	0	0	-
27.00	2.25	5.90	0.00	4.075	0.00	0.00 %	0	0	-
28.00	1.25	4.90	0.00	3.075	0.00	0.00 %	0	0	-
29.00	0.25	3.90	0.00	2.075	0.00	0.00 %	0	0	-
30.00	0.20	3.00	0.00	1.60	0.00	0.00 %	0	0	-
31.00	0.00	2.35	0.00	0.00	0.00	0.00 %	0	0	-
32.00	0.00	2.05	0.00	0.00	0.00	0.00 %	0	0	-
33.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
34.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
35.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
36.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
37.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
38.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
39.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
40.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Premium

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
21.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
22.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
23.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
24.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
26.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
27.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
28.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
29.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	2.05	0.00	0.00	0.00	0.00 %	0	0	-
31.00	0.00	2.40	0.00	0.00	0.00	0.00 %	0	0	-
32.00	0.00	3.20	0.00	0.00	0.00	0.00 %	0	0	-
33.00	0.25	4.10	0.00	2.175	0.00	0.00 %	0	0	-
34.00	1.20	4.90	0.00	3.05	0.00	0.00 %	0	0	-
35.00	2.10	5.90	0.00	4.00	0.00	0.00 %	0	0	-
36.00	3.10	6.90	0.00	5.00	0.00	0.00 %	0	0	-
37.00	4.10	7.90	0.00	6.00	0.00	0.00 %	0	0	-
38.00	5.10	8.90	0.00	7.00	0.00	0.00 %	0	0	-
39.00	6.10	9.90	0.00	8.00	0.00	0.00 %	0	0	-
40.00	7.10	10.90	0.00	9.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHOEShoe Station Group Inc	US$ 16.85 (16,750.00%)	590.42k
CASTFreeCast Inc	US$ 3.73 (140.65%)	158.15M
CUPRCuprina Holdings Cayman Ltd	US$ 8.48 (113.60%)	48.56M
VSMEVS Media Holdings Ltd	US$ 3.25 (92.31%)	64.72M
PRFXPRF Technologies Ltd	US$ 2.4801 (82.36%)	47.33M
ELTXElicio Therapeutics Inc	US$ 4.07 (-72.59%)	8.46M
MEHAFunctional Brands Inc	US$ 0.01845 (-55.43%)	77.56M
CNTXContext Therapeutics Inc	US$ 0.6794 (-51.12%)	20.59M
NMRANeumora Therapeutics Inc	US$ 0.9177 (-48.44%)	17.74M
SNBRSleep Number Corporation	US$ 0.2202 (-43.57%)	17.1M
ADTXAditxt Inc	US$ 0.013 (2.36%)	827.76M
PAVSParanovus Entertainment Technology Ltd	US$ 0.177 (-14.90%)	671.36M
SPCXSpace Exploration Technologies Corporation	US$ 192.50 (19.60%)	256.78M
WOKWORK Medical Technology Group Ltd	US$ 0.0856 (13.68%)	199.07M
GDCGD Culture Group Ltd	US$ 0.1034 (4.44%)	190.17M

US Market News

US Market News 2 minutes ago

Unilever Scales Digital Twins Across Global Manufacturing Network with AccentureJune 16, 2026 2:59 AM
Business WireUnilever (LON: ULVR) is partnering with Accenture (NYSE: ACN) to scale the use of AI-enabled digital twins across its global manufacturing network

CelestialSage6

CelestialSage6 4 minutes ago

You can't refute it. Yes, I understand your level well.

biotechinvestor1

biotechinvestor1 10 minutes ago

Total nonsense! I have no interest in educating you.

Nemesis18

Nemesis18 11 minutes ago

She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?

price_and_volume

price_and_volume 13 minutes ago

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

StockItOut

StockItOut 14 minutes ago

WKSP Weekly chart: https://schrts.co/IIIuZpgy

CelestialSage6

CelestialSage6 15 minutes ago

I understand that Halozyme has not signed any exclusive agreements regarding treatments or indications related to Dupixent, so why is Sanofi collaborating with Alteogen?

Also, Halozyme's mdase patent is being invalidated due to Merck. Alteogen's technology is more advanced than Halozy

Wolf-man jack

Wolf-man jack 17 minutes ago

WQLF SAYS: Have Mercy WQLF ahoooooo

Q: Why hasn't CV SCIENCES been accepted in the CMS Medicare Pilot Program?

Ai Generated:

C V Sciences has not been "accepted" into the CMS Medicare Pilot Program because the pilot is a provider-led incentive, not a

price_and_volume

price_and_volume 18 minutes ago

What reasonable expectation is there of PPS responding?
whether management can successfully execute on the vision they have laid out. Nobody cares about "the company" or "the management" or "their vision" or your two-bit-MBA-tutorials-in-a-post.

Enough of all that garbage.

mrwrn2010

mrwrn2010 21 minutes ago

Disagree. The outcome of OxyContin litigation was unknown 9 months to a year ago. You can guess at a variety of outcomes, sure, but it’s not certain. Same thing with human trials - we don’t have positive trial results for anything in the pipeline until we have them. What passes in vitro may not pass

PEACHMAN

PEACHMAN 23 minutes ago

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177680761

IFUS STRONG

price_and_volume

price_and_volume 24 minutes ago

I get that, but that's not what I asked.

I'm not bullying you or accusing you of pumping.

You repeatedly point out what you consider to be nefarious shenanigans, so I asked: PPS hasn't effectively changed in THREE YEARS , other than a few short days 1 year ago this wee

Homework.Investwell

Homework.Investwell 30 minutes ago

2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800

Suite 800 is empty....🤔

Linda lives in Missouri now but headquarters could be moved anywhere...or will they need it?

I think we're going to find out by the end of the sum

Mdk1

Mdk1 32 minutes ago

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 39 minutes ago

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 42 minutes ago

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

HyGro 46 minutes ago

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 47 minutes ago

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

HyGro 49 minutes ago

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 51 minutes ago

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 51 minutes ago

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

HyGro 52 minutes ago

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

HyGro 53 minutes ago

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Mdk1 57 minutes ago

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 59 minutes ago

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

SAP SE ADRhedged

One World Lithium (PK)

Simplify Commodities Str...

AB Global Disruptors Por...

Vertex Pharmaceuticals

China Resources Pharmace...

Invesco Electric Vehicle...

Gryscalefinance

First Trust Dow Jones In...

1.375% until 28/05/2029 ...

Wisdomtree Core Physical...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.